Article List

WPRIM Management System> DCMS> Cancer Research and Treatment> 2003> 35> 4

1. Second-Line Chemotherapy for Advanced Non-small Cell Lung Cancer: Past, Present, and Hope for the Future.	Page:279—280
2. Metastatic Anaplastic Carcinoma of the Small Intestine Arising from The Lung.	Page:364—366
3. The Expressions of Cytokeratin 7 and 20 in Epithelial Tumors: A Survey of 91 Cases.	Page:355—363
4. Clinical Value of Whole Body F-18 FDG PET in The Management of Recurrent Colorectal Malignancy.	Page:349—354
5. TRAIL-Mediated Apoptosis in Human Liver Chang Cells.	Page:341—348
6. Clinical Significance of the Levels of Serum Cholesterol in Patients with Gastric Cancer.	Page:335—340
7. Concurrent FP (5-fluorouracil, cisplatin) Chemoradiotherapy for Patients with Esophageal Cancer.	Page:330—334
8. Prognostic Significance of KAI-1 and Survivin Expressions in Ovarian Epithelial Carcinomas.	Page:323—329
9. Alterations in Promoter Usage and Expression Levels of Insulin-like Growth Factor-II and H19 Genes in Cervical and Endometrial Cancer.	Page:314—322
10. New Approaches to Functional Process Discovery in HPV 16-Associated Cervical Cancer Cells by Gene Ontology.	Page:304—313
11. Effect of Combination Chemotherapy with Docetaxel Plus Cisplatin in Patients with Advanced Non-Small Cell Lung Cancer.	Page:299—303
12. Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer.	Page:294—298
13. Microsatellite Alterations in Serum DNA of Lung Cancer Patients.	Page:289—293
14. Advances in Nuclear Oncology.	Page:281—288